CCAAT/enhancer binding protein beta regulates stem cell activity and specifies luminal cell fate in the mammary gland

Stem Cells

Volumn 28, Issue 3, 2010, Pages 535-544

  LaMarca, Heather L ^a   Visbal, Adriana P ^a   Creighton, Chad J ^a   Liu, Hao ^a   Zhang, Yiqun ^a   Behbod, Fariba ^b   Rosen, Jeffrey M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Alveolar; C EBP beta; Differentiation; Lineage commitment; Luminal; Mammary stem cell; Progenitor cell

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST EPITHELIUM; CELL ACTIVITY; CELL FATE; CELL LINEAGE; CELL TRANSPLANTATION; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; GENE DELETION; GERM LINE; MAMMARY GLAND; MOUSE; NONHUMAN; NULL ALLELE; REGULATORY MECHANISM; STEM CELL; WILD TYPE;

ANIMALS; BIOLOGICAL MARKERS; BREAST NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL AGING; CELL COMPARTMENTATION; CELL DEATH; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MAMMARY GLANDS, ANIMAL; MICE; MICE, KNOCKOUT; ORGANOGENESIS; STEM CELLS;

EID: 77950558347     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.297     Document Type: Article

References (54)

1. Asselin-Labat ML, Sutherland KD, Barker H et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 2007;9:201-209.
2. Shackleton M, Vaillant F, Simpson KJ et al. Generation of a functional mammary gland from a single stem cell. Nature 2006;439: 84-88.
3. Sleeman KE, Kendrick H, Robertson D et al. Dissociation of estrogen receptor expression and in vivo stem cell activity in the mammary gland. J Cell Biol 2007;176:19-26.
4. Stingl J, Eaves CJ, Zandieh I et al. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res Treat 2001;67:93-109.
5. Stingl J, Eirew P, Ricketson I et al. Purification and unique properties of mammary epithelial stem cells. Nature 2006;439:993-997.
6. Eirew P, Stingl J, Raouf A et al. A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat Med 2008;14:1384-1389.
7. Lim E, Vaillant F, Wu D et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 2009;15:907-913.
8. Nerlov C. The C/EBP family of transcription factors: A paradigm for interaction between gene expression and proliferation control. Trends Cell Biol 2007;17:318-324.
9. Gigliotti AP, DeWille JW. Lactation status influences expression of CCAAT/enhancer binding protein isoform mRNA in the mouse mammary gland. J Cell Physiol 1998;174:232-239.
10. Grimm SL, Rosen JM. The role of C/EBPbeta in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 2003; 8:191-204.
11. Robinson GW, Johnson PF, Hennighausen L et al. The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev 1998;12:1907-1916.
12. Grimm SL, Seagroves TN, Kabotyanski EB et al. Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development. Mol Endocrinol 2002;16: 2675-2691.
13. Seagroves TN, Krnacik S, Raught B et al. C/EBPbeta, but not C/ EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev 1998;12:1917-1928.
14. Seagroves TN, Lydon JP, Hovey RC et al. C/EBPbeta (CCAAT/ enhancer binding protein) controls cell fate determination during mammary gland development. Mol Endocrinol 2000;14:359-368.
15. Kouros-Mehr H, Slorach EM, Sternlicht MD et al. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 2006;127:1041-1055.
16. Li W, Ferguson BJ, Khaled WT et al. PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. Proc Natl Acad Sci U S A 2009; 106:4725-4730.
17. Oakes SR, Naylor MJ, Asselin-Labat ML et al. The Ets transcription factor Elf5 specifies mammary alveolar cell fate. Genes Dev 2008;22: 581-586.
18. Sterneck E, Tessarollo L, Johnson PF. An essential role for C/EBPbeta in female reproduction. Genes Dev 1997;11:2153-2162.
19. Sterneck E, Zhu S, Ramirez A et al. Conditional ablation of C/EBP beta demonstrates its keratinocyte-specific requirement for cell survival and mouse skin tumorigenesis. Oncogene 2006;25:1272-1276.
20. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999;21:70-71.
21. Welm BE, Dijkgraaf GJ, Bledau AS et al. Lentiviral transduction of mammary stem cells for analysis of gene function during development and cancer. Cell Stem Cell 2008;2:90-102.
22. Moraes RC, Zhang X, Harrington N et al. Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia. Development 2007;134:1231-1242.
23. Rijnkels M, Rosen JM. Adenovirus-Cre-mediated recombination in mammary epithelial early progenitor cells. J Cell Sci 2001;114: 3147-3153.
24. Dontu G, Abdallah WM, Foley JM et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003;17:1253-1270.
25. Deome KB, Faulkin LJ, Jr., Bern HA et al. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 1959;19: 515-520.
26. Wagner KU, Wall RJ, St-Onge L et al. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res 1997;25:4323-4330.
27. Bonnefoix T, Bonnefoix P, Verdiel P et al. Fitting limiting dilution experiments with generalized linear models results in a test of the single-hit Poisson assumption. J Immunol Methods 1996;194:113-119.
28. Bonnefoix T, Bonnefoix P, Callanan M et al. Graphical representation of a generalized linear model-based statistical test estimating the fit of the single-hit Poisson model to limiting dilution assays. J Immunol 2001;167:5725-5730.
29. Dontu G, Wicha MS. Survival of mammary stem cells in suspension culture: Implications for stem cell biology and neoplasia. J Mammary Gland Biol Neoplasia 2005;10:75-86.
30. Daniel CW, Young LJ, Medina D et al. The influence of mammogenic hormones on serially transplanted mouse mammary gland. Exp Gerontol 1971;6:95-101.
31. Asselin-Labat ML, Shackleton M, Stingl J et al. Steroid hormone receptor status of mouse mammary stem cells. J Natl Cancer Inst 2006; 98:1011-1014.
32. Taddei I, Deugnier MA, Faraldo MM et al. Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat Cell Biol 2008;10:716-722.
33. Paguirigan A, Beebe DJ, Alexander CM. Simulating mouse mammary gland development: Cell ageing and its relation to stem and progenitor activity. Cell Prolif 2007;40:106-124.
34. Sebastian T, Johnson PF. RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence. Cancer Res 2009;69:2588-2598.
35. Pietersen AM, Evers B, Prasad AA et al. Bmi1 regulates stem cells and proliferation and differentiation of committed cells in mammary epithelium. Curr Biol 2008;18:1094-1099.
36. Hata K, Nishimura R, Ueda M et al. A CCAAT/enhancer binding protein beta isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes. Mol Cell Biol 2005;25: 1971-1979.
37. LaMarca HL, Rosen JM. Minireview: Hormones and mammary cell fate-what will I become when I grow up? Endocrinology 2008;149: 4317-4321.
38. Stingl J. Detection and analysis of mammary gland stem cells. J Pathol 2009;217:229-241.
39. Visvader JE, Lindeman GJ. Mammary stem cells and mammopoiesis. Cancer Res 2006;66:9798-9801.
40. Alvi AJ, Clayton H, Joshi C et al. Functional and molecular characterisation of mammary side population cells. Breast Cancer Res 2003;5: R1-8.
41. Booth BW, Boulanger CA, Smith GH. Alveolar progenitor cells develop in mouse mammary glands independent of pregnancy and lactation. J Cell Physiol 2007;212:729-736.
42. Wagner KU, Boulanger CA, Henry MD et al. An adjunct mammary epithelial cell population in parous females: Its role in functional adaptation and tissue renewal. Development 2002;129:1377-1386.
43. Bouras T, Pal B, Vaillant F et al. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell 2008;3:429-441.
44. Raouf A, Zhao Y, To K et al. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 2008;3:109-118.
45. Buono KD, Robinson GW, Martin C et al. The canonical Notch/RBPJ signaling pathway controls the balance of cell lineages in mammary epithelium during pregnancy. Dev Biol 2006;293:565-580.
46. Chen H, Chong Y, Liu CL. Active intracellular domain of Notch enhances transcriptional activation of CCAAT/enhancer binding protein beta on a rat pregnancy-specific glycoprotein gene. Biochemistry 2000;39:1675-1682.
47. Wang X, Pasolli HA, Williams T et al. AP-2 factors act in concert with Notch to orchestrate terminal differentiation in skin epidermis. J Cell Biol 2008;183:37-48.
48. Gustafson TL, Wellberg E, Laffin B et al. Ha-Ras transformation of MCF10A cells leads to repression of Singleminded-2s through NOTCH and C/EBPbeta. Oncogene 2009;28:1561-1568.
49. Wei Y, Puzhko S, Wabitsch M et al. Transcriptional regulation of the human growth hormone receptor (hGHR) gene V2 promoter by transcriptional activators and repressor. Mol Endocrinol 2009;23:373-387.
50. Tosh D, Shen CN, Slack JM. Conversion of pancreatic cells to hepatocytes. Biochem Soc Trans 2002;30:51-55.
51. ß are targeted by miR-155 in B cells of Eμ-miR-155 transgenic mice. Blood 2009;114:1374-1382.
52. Zhu S, Yoon K, Sterneck E et al. CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival, skin tumorigenesis involving oncogenic Ras signaling. Proc Natl Acad Sci U S A 2002;99: 207-212.
53. Zahnow CA, Younes P, Laucirica R et al. Overexpression of C/EBP-beta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer. J Natl Cancer Inst 1997;89:1887-1891.
54. Gomis RR, Alarcon C, Nadal C et al. C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 2006;10:203-214.